Please assess the completion status of the following clinical trial:

Trial Title: Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. 18 years or older with a diagnosis of T2DM with a scheduled office visit with primary care provider within the next 4 weeks~2. Last 2 HbA1c values between 7.5 - 10% measured in the last 12 months~3. Treated with non-insulin therapies or therapeutic lifestyle changes~4. Never worn professional CGM or have not worn in last 12 months~5. Willing to perform requirements needed for professional CGM~Exclusion Criteria:~1. Current or previous treatment with any insulin within 3 months at baseline

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 3-Month iPro2 Professional CGM (Type: EXPERIMENTAL): Professional CGM measures interstitial glucose every 5 minutes via a glucose-oxidase-impregnated membrane during a 3 day period. The patient wearing professional CGM is blinded to the repeated measurements and the data is stored for retrospective analysis.
- 6-Month iPro2 Professional CGM (Type: EXPERIMENTAL): Professional CGM measures interstitial glucose every 5 minutes via a glucose-oxidase-impregnated membrane during a 3 day period. The patient wearing professional CGM is blinded to the repeated measurements and the data is stored for retrospective analysis.

Based on this trial design, predict the completion outcome and termination type (if applicable).